Skip to Content

The Now Corp NWPN

Morningstar Rating
$0.00 0.00 (50.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NWPN is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$2.72
Uncertainty
Extreme
1-Star Price
$7.16
5-Star Price
$6.27
Economic Moat
Ftyf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NWPN is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$49,462.76
Volume/Avg
34.2 Mil / 59.1 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

The Now Corp is a biopharmaceutical research company. The company focused on the research, education, and production of Scientific-Grade Cannabidiol (CBD) from hemp and Tetrahydrocannabinol (THC) to be used for medicinal purposes. It provides Credible Scientific Research Data to the heavily regulated medical and recreational marijuana industries.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees

Valuation

Metric
NWPN
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
NWPN
Quick Ratio
Current Ratio
Interest Coverage
−0.24
Quick Ratio
NWPN

Profitability

Metric
NWPN
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AYsgdvdgdkStpt$70.0 Bil
MKKGY
Merck KGaA ADRSgvnrxssfZpdtyr$67.6 Bil
HLN
Haleon PLC ADRYvsptvsbPlgg$36.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRCktnqhfgXrwq$14.3 Bil
VTRS
Viatris IncLxxjjwmvXjbw$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRJyywmfxhNhgl$11.9 Bil
CTLT
Catalent IncTwbnynkpNytqw$10.0 Bil
PRGO
Perrigo Co PLCSsghqlsMgx$4.1 Bil
CURLF
Curaleaf Holdings IncWqhwdtjMsgc$3.6 Bil
PBH
Prestige Consumer Healthcare IncMpmvrrhwyThyqdb$3.4 Bil

Sponsor Center